Evidence map›Paper›PMID 41415882›Full record

ReviewJournal of biological methods2025

Role of vinegar in cardiovascular health: A narrative review.

Ridah Ijaz, Raymond Haward

Abstract readReview
In one paragraph

Review in Journal of biological methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ridah IjazDepartment of Internal Medicine, Khyber Girls Medical College, Peshawar, Khyber Pakhtunkhwa 25100, Pakistan.
Raymond HawardDepartment of Cardiology, Vydehi Institute of Medical Sciences and Research Centre, Bengaluru 560066, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiovascular diseases remain the leading cause of mortality globally, driven largely by modifiable risk factors, such as hyperlipidemia, hypertension, diabetes, and oxidative stress. As conventional pharmaceutical interventions often carry adverse effects and economic burdens, there is growing interest in alternative therapies. Objective: This narrative review explores vinegar, a traditional remedy with historical and cross-cultural usage, as a potential adjunct in cardiovascular health management. Vinegar contains a rich array of bioactive compounds, including acetic acid, polyphenols, amino acids, melanoidins, and tetramethylpyrazine, which may exert antioxidant, anti-inflammatory, lipid-lowering, antihypertensive, and antithrombotic effects. Preclinical studies in animal models and limited human trials indicate promising outcomes in improving lipid profiles, blood pressure regulation, glycemic control, and endothelial function. Despite these benefits, there is a paucity of large-scale, high-quality human studies to validate vinegar's clinical efficacy and safety. Conclusion: This review underscores the potential of vinegar as a functional food with cardioprotective properties and advocates for further rigorous research to establish standardized dosing, isolate active constituents, and assess long-term outcomes in human populations.

Indexed as

Cardiovascular diseaseHeartNaturopathyVinegar

Identifiers

PMID41415882
PMCPMC12709512

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.